Amyloid PET results may not influence drug treatment, since acetylcholinesterase inhibitors are indicated in both DLB and AD, and anti-amyloid antibody treatment would not be currently indicated in patients with clinical features of DLB. Here, ACHE is linked to Lewy body dementia.